Infliximab‐induced autoimmune hepatitis requiring liver transplantation

Abstract

Abstract Autoimmune hepatitis is an infrequent but significant side effect of infliximab treatment. Diagnosis of autoimmune hepatitis is based on clinical, laboratory, and histological findings. Initial treatment involves cessation of infliximab and trial of prednisone. We present a rare case of infliximab‐induced autoimmune hepatitis leading to liver failure requiring transplantation.

Keywords

• autoimmune hepatitis
• Crohn's disease
• infliximab
• liver transplantation